Search research articles
Contact Us
Filters
Showing results (1-10 of 169) with videos related to
Page
of 17
Sort By:
Biomolecules
|
September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment Options
Nik Krajnc, Thomas Berger, Gabriel Bsteh
Cephalalgia : an International Journal of Headache
|
September 2, 2020
Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case report
Gabriel Bsteh, Christian Bsteh, Gregor Broessner
Frontiers in Neurology
|
September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
Nik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology
|
April 8, 2026
Assessing treatment response in multiple sclerosis
Fabian Föttinger, Nik Krajnc, Gabriel Bsteh
Current Pharmaceutical Design
|
February 1, 2022
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis
Stefan Macher, Gabriel Bsteh, Thomas Berger, et al.
Pharmacological Reviews
|
May 8, 2024
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis
Gabriel Bsteh, Assunta Dal Bianco, Tobias Zrzavy, et al.
Plos One
|
August 2, 2019
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis
Rainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
Nik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Biomedicines
|
November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?
Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Annals of Clinical and Translational Neurology
|
August 7, 2023
Clinical scales in autoimmune encephalitis-A retrospective monocentric cohort study
Stefan Macher, Gabriel Bsteh, Romana Höftberger, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 169) with videos related to
Sort By:
Page
of 17
Biomolecules
|
September 28, 2021
Measuring Treatment Response in Progressive Multiple Sclerosis-Considerations for Adapting to an Era of Multiple Treatment Options
Nik Krajnc, Thomas Berger, Gabriel Bsteh
Cephalalgia : an International Journal of Headache
|
September 2, 2020
Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case report
Gabriel Bsteh, Christian Bsteh, Gregor Broessner
Frontiers in Neurology
|
September 13, 2021
Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
Nik Krajnc, Gabriel Bsteh, Thomas Berger
Current Opinion in Neurology
|
April 8, 2026
Assessing treatment response in multiple sclerosis
Fabian Föttinger, Nik Krajnc, Gabriel Bsteh
Current Pharmaceutical Design
|
February 1, 2022
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis
Stefan Macher, Gabriel Bsteh, Thomas Berger, et al.
Pharmacological Reviews
|
May 8, 2024
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis
Gabriel Bsteh, Assunta Dal Bianco, Tobias Zrzavy, et al.
Plos One
|
August 2, 2019
Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis
Rainer Ehling, Gabriel Bsteh, Andreas Muehlbacher, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management
Nik Krajnc, Gabriel Bsteh, Thomas Berger, et al.
Biomedicines
|
November 11, 2022
Immunosenescence in Neurological Diseases-Is There Enough Evidence?
Paulus S Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Annals of Clinical and Translational Neurology
|
August 7, 2023
Clinical scales in autoimmune encephalitis-A retrospective monocentric cohort study
Stefan Macher, Gabriel Bsteh, Romana Höftberger, et al.
Page
of 17